• 5218 Citations
  • 35 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Intensity-Modulated Radiotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Chemoradiotherapy Medicine & Life Sciences
Nasopharyngeal carcinoma Medicine & Life Sciences
Induction Chemotherapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

  • 5218 Citations
  • 35 h-Index
  • 265 Article
  • 3 Letter
  • 3 Review article

10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma

Chen, L., Zhang, Y., Lai, S. Z., Li, W. F., Hu, W. H., Sun, R., Liu, L. Z., Zhang, F., Peng, H., Du, X. J., Lin, A. H., Sun, Y. & Ma, J., Jan 1 2019, In : Oncologist. 24, 1, p. e38-e45

Research output: Contribution to journalReview article

Intensity-Modulated Radiotherapy
Radiotherapy
Confidence Intervals
Survival
Therapeutics

ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma

Peng, H., Zhang, J., Zhang, P. P., Chen, L., Tang, L. L., Yang, X. J., He, Q. M., Wen, X., Sun, Y., Liu, N., Li, Y. Q. & Ma, J., Jan 8 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 11.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptor Nuclear Translocator
Cyclin-Dependent Kinase 5
Cisplatin
Carcinogenesis
Cell Line

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy

Sun, X. S., Liu, L. T., Liu, S. L., Guo, S. S., Wen, Y. F., Xie, H. J., Tang, Q. N., Liang, Y. J., Li, X. Y., Yan, J. J., Ma, J., Chen, Q. Y., Tang, L. Q. & Mai, H-Q., Jan 21 2019, In : BMC cancer. 19, 1, 1 p.

Research output: Contribution to journalArticle

Human Herpesvirus 4
Cohort Studies
Retrospective Studies
Drug Therapy
DNA

Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort

Peng, L., Xu, C., Chen, Y. P., Guo, R., Mao, Y. P., Sun, Y., Ma, J. & Tang, L. L., Feb 1 2019, In : Oral Oncology. 89, p. 102-106 5 p.

Research output: Contribution to journalArticle

Cisplatin
Radiotherapy
Chemoradiotherapy
Survival
Nasopharyngeal carcinoma

Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma

Guo, R., Tang, L. L., Mao, Y. P., Du, X. J., Chen, L., Zhang, Z. C., Liu, L. Z., Tian, L., Luo, X. T., Xie, Y. B., Ren, J., Sun, Y. & Ma, J., Jan 1 2019, In : Cancer. 125, 1, p. 79-89 11 p.

Research output: Contribution to journalArticle

Neoplasm Staging
Human Herpesvirus 4
DNA
Intensity-Modulated Radiotherapy
Disease-Free Survival